Skip to content

iFoot - Improving inter-facility care for people with diabetic foot syndrome (DFS) using eHealth. A prospective, multicentre, randomized trial.

iFoot - Improving inter-facility care for people with diabetic foot syndrome (DFS) using eHealth. A prospective, multicentre, randomized trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00023094
Enrollment
40
Registered
2021-02-05
Start date
2021-02-22
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic foot in persons with DM Typ 1 Diabetic foot in persons with DM Typ 2 E10.74

Interventions

Group 1: Intervention group: Intelligent iFoot bandage integrating offloading with monitoring of pressure, humidity and temperature and communication of the results to the patients and their physician

Sponsors

Amb. Zentrum für Diabetologie, Endoskopie und Wundheilung Köln
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1.) Type1 diabetes, type2 diabetes, or type3 diabetes between 18 years and 85 years of age. 2.) Polyneuropathy 3.) Pressure ulcer 3.1) Wound plantar, pressure related, bony prominence palpable under wound 3.2) Pressure ulcers on the heel dorsal 4.) ulcers stage 1 or 2 after Wagner or stage 3 after surgical rehabilitation

Exclusion criteria

Exclusion criteria: 1.) Active Charcot foot, 2.) Tumor less than 5 years in remission, 3.) Severe disease which reduces life expectancy less than 6 months 4.) Severe mental illness 5.) Ulcer stage 3 or higher according to Wagner without surgical rehabilitation 6.) Necrotic wound areas at the time of randomization 7.) PAD in need of revascularization 8.) Permanent accessibility of the patient is not guaranteed

Design outcomes

Primary

MeasureTime frame
Time until the wound area is halved

Secondary

MeasureTime frame
Time until wound closure, number if intervisit-intervals with enlargement of wound area, Economiy, QoL

Countries

Germany

Contacts

Public ContactDirk Hochlenert

Amb. Zentrum für Diabetologie, Endoskopie und Wundheilung Köln

dirk.hochlenert@cid-direct.de0221 9731610

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026